Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INFANT BACTERIAL THERAPEUTICS AB (PUBL)

(IBT B)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Infant Bacterial Therapeutics AB Announces CFO Changes

05/20/2021 | 10:30am EDT

Infant Bacterial Therapeutics AB announced CFO Daniel Mackey has decided to leave the company to pursue new challenges. He will remain in his current role during his notice period. Michael Owens will be acting CFO when Daniel leaves the company and until his replacement is in place. The recruitment process has already been initiated.


ę S&P Capital IQ 2021
All news about INFANT BACTERIAL THERAPEUTICS AB (PUBL)
08:05aINFANT BACTERIAL THERAPEUTICS : IBT - After safety review The Connection study is now agai..
AQ
09/22INFANT BACTERIAL THERAPEUTICS : After safety review The Connection study is now again open..
AQ
09/13INFANT BACTERIAL THERAPEUTICS : announces that a new patent is granted in Mexico
AQ
09/10INFANT BACTERIAL THERAPEUTICS : today announces that a new patent is granted in Mexico
AQ
09/10Infant Bacterial Therapeutics Announces the Mexican Patent Office Grants New Patent
CI
08/25INFANT BACTERIAL THERAPEUTICS : Recruitment of the smallest infants in the Connection stud..
AQ
08/25Infant Bacterial Therapeutics AB Announces Recruitment of the Smallest Infants in the C..
CI
08/16INFANT BACTERIAL THERAPEUTICS AB : (publ) Interim Management Statement, January 1 - June 3..
AQ
08/13INFANT BACTERIAL THERAPEUTICS AB : (publ) Interim Management Statement,áJanuary 1 – ..
AQ
08/13Infant Bacterial Therapeutics AB Announces Interim Management Statement for the Second ..
CI
More news
Financials
Sales 2020 - - -
Net income 2020 -72,0 M -8,34 M -8,34 M
Net cash 2020 423 M 49,0 M 49,0 M
P/E ratio 2020 -17,5x
Yield 2020 -
Capitalization 828 M 95,9 M 96,0 M
EV / Sales 2019 -
EV / Sales 2020 -
Nbr of Employees 8
Free-Float 89,2%
Chart INFANT BACTERIAL THERAPEUTICS AB (PUBL)
Duration : Period :
Infant Bacterial Therapeutics AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INFANT BACTERIAL THERAPEUTICS AB (PUBL)
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Managers and Directors
Staffan Str÷mberg Chief Executive Officer
Marie-Louise Alamaa Chief Financial Officer
Peter Michael Rothschild Chairman
Eamonn Connolly Chief Scientific Officer
Jonas Rastad Chief Medical Officer